:

Luojia Dai1, Zhenqiu Liu2, Chengnan Guo3

  • 1Department of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety (Fudan University), Ministry of Education, Fudan University, Shanghai 200032, China.

Life sciences
|April 26, 2025
PubMed
概括

这项研究确定了与代谢功能障碍相关的脂肪性肝病 (MASLD) 相关的关键血蛋白. 干白素-6 (IL-6) 和5-HT7R显示风险增加,而α-1-抗素可能具有保护作用,为MASLD提供潜在的新药标.